Out of Stock

heparin inj 5000 iu 1 vial


Highlights

  • This medication is used to prevent and treat blood clots.
  • It may be used to prevent and treat blood clots in the lungs/legs (including in patients with atrial fibrillation).
  • It may be used to treat certain blood clotting disorders.


Description

Heparin inj 5000 IU 1 vial

  • Heparin injection contains heparin.
  • Belongs to anticoagulant.
  • Heparin injection 5000 IU 1 Vial works by decreasing the clotting ability of the blood.


Directions For Use

  • By continuous intravenous infusion in 5% glucose or 0.9% sodium chloride or by intermittent intravenous injection or by subcutaneous injection given by a health care professional.


Warnings

  • This medicine is recommended for use in pregnant women only when absolutely necessary and the potential benefits outweigh the risks involved.
  • This medicine is recommended for use in breastfeeding women only when absolutely necessary and the potential benefits outweigh the risks involved.


Precautions

  • Heparin should be used with caution in patients with hypersensitivity to low molecular weight heparin.
  • Care should be taken when heparin is administered to patients with increased risk of bleeding complications, hypertension, renal or hepatic insufficiency.
  • Heparin can suppress adrenal secretion of aldosterone leading to hyperkalaemia particularly in patients such as those with diabetes mellitus, chronic renal failure, pre-existing metabolic acidosis, a raised plasma potassium or taking potassium sparing drugs. The risk of hyperkalaemia appears to increase with duration of therapy but is usually reversible. Plasma potassium should be measured in patients at risk before starting heparin therapy and monitored regularly thereafter particularly if treatment is prolonged beyond about 7 days.
  • In patients undergoing peri-dural or spinal anaesthesia or spinal puncture the prophylactic use of heparin may be very rarely associated with epidural or spinal haematoma resulting in prolonged or permanent paralysis.